J. Joseph Kim
2017
In 2017, J. Joseph Kim earned a total compensation of $4.4M as President, Chief Executive Officer and Director at Inovio Pharmaceuticals, a 48% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $353,600 |
|---|---|
| Option Awards | $188,818 |
| Salary | $780,007 |
| Stock Awards | $3,051,725 |
| Other | $15,118 |
| Total | $4,389,268 |
Kim received $3.1M in stock awards, accounting for 70% of the total pay in 2017.
Kim also received $353.6K in non-equity incentive plan, $188.8K in option awards, $780K in salary and $15.1K in other compensation.
Rankings
In 2017, J. Joseph Kim's compensation ranked 2,276th out of 14,666 executives tracked by ExecPay. In other words, Kim earned more than 84.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,276 out of 14,666 | 85th |
Division Manufacturing | 793 out of 5,768 | 86th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 102 out of 856 | 88th |
Industry group Surgical, Medical, And Dental Instruments And Supplies | 52 out of 528 | 90th |
Industry Surgical and Medical Instruments and Apparatus | 32 out of 333 | 90th |
Source: SEC filing on March 28, 2018.
Kim's colleagues
We found three more compensation records of executives who worked with J. Joseph Kim at Inovio Pharmaceuticals in 2017.
News
Inovio Pharmaceuticals CEO J Kim's 2022 pay jumps 68% to $10M
March 28, 2023
Inovio Pharmaceuticals CEO J Kim's 2021 pay jumps 32% to $6.2M
March 25, 2022
Inovio Pharmaceuticals CEO J Kim's 2020 pay jumps 82% to $4.7M
March 25, 2021
Inovio Pharmaceuticals CEO J Kim's 2018 pay falls 30% to $3.1M
March 25, 2019